July 16, 2012
TPG to buy generic drugmaker Par for $1.9 bln
By Lewis Krauskopf
Private equity firm TPG said on Monday it would acquire U.S.-based Par Pharmaceutical Cos Inc for $1.9 billion, the latest acquisition in the generic drug industry...
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.